SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 860.81 |
| Enterprise Value ($M) | 1,827.93 |
| Book Value ($M) | 228.84 |
| Book Value / Share | 7.12 |
| Price / Book | 3.76 |
| NCAV ($M) | -977.49 |
| NCAV / Share | -30.42 |
| Price / NCAV | -0.88 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.05 |
| Return on Assets (ROA) | 0.06 |
| Return on Equity (ROE) | 0.31 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.95 |
| Current Ratio | 1.03 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 457.26 |
| Assets | 1,663.59 |
| Liabilities | 1,434.75 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 631.45 |
| Operating Income | 166.98 |
| Net Income | 69.19 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 204.98 |
| Cash from Investing | -287.76 |
| Cash from Financing | -60.60 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 15.60 | -13.63 | |
| 13G | Rubric Capital Management LP | 7.29 | 88.00 | |
| 13G | Invesco Ltd. | 5.50 | ||
| 13G | Principal Global Investors | 5.42 | ||
| 13G | Renaissance Technologies Llc | 5.14 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES | ||
| UNITED STATES | ||
| UNITED STATES | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 21,686 | 117,032 | 18.53 | |
| 42,157 | 174,861 | 24.11 | |
| 34,884 | 213,373 | 16.35 | |
| 70,228 | 302,607 | 23.21 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CGEM – Cullinan Therapeutics, Inc. | CGON – CG Oncology, Inc. |
| COGT – Cogent Biosciences, Inc. | CPIX – Cumberland Pharmaceuticals Inc. |
| CRBU – Caribou Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io